• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定前列腺癌避免不必要活检的相对概率。

Determination of the relative probability for prostate cancer to avoid unnecessary biopsy.

作者信息

Okamura Kikuo, Takaba Hidenori, Kamihira Osamu, Kinukawa Tsuneo, Ono Yoshinari, Ohshima Shinichi, Nagasaka Tetsuro

机构信息

Depatment of Urology, National Center for Geriatrics and Gerontology, Obu, Japan.

出版信息

Int J Urol. 2005 Apr;12(4):346-52. doi: 10.1111/j.1442-2042.2005.01056.x.

DOI:10.1111/j.1442-2042.2005.01056.x
PMID:15948720
Abstract

BACKGROUND

To investigate whether using a new concept of relative probability for prostate cancer (RPpca) can increase sensitivity and specificity in detecting prostate cancer.

METHODS

For 217 patients with total prostate-specific antigen (PSA) level of 4-20 ng/mL, prostate volume and free to total PSA (F/T) ratio were measured. From the fitted curves between positive predictive values for prostate cancer and age, prostate volume, total PSA or the F/T ratio, each function predicting prostate cancer was determined. RPpca defined by the combined functions of age, prostate volume, total PSA and F/T ratio was calculated for each individual patient. The probability of prostate cancer was also calculated, using logistic regression analysis (LRPpca). Receiver-operating characteristic analysis was performed to elucidate the areas under the curve (AUC), sensitivities and specificities and cutoff values of the conventional and new parameters. Finally, we investigated the applicability of the above parameters in the other patient group using a different PSA assay kit (AxSYM).

RESULTS

Although RPpca had the largest AUC in the total PSA range of 4-20 ng/mL, it did not reach statistical significance between RPpca and F/T ratio or LRPpca. The cutoff values of F/T ratio, LRPpca and RPpca were determined as 0.15, 0.12 and 0.20, respectively. Using these cutoff values in AxSYM data, RPpca had the highest sensitivity (91%) and specificity (57%).

CONCLUSIONS

RPpca can provide more precise information to avoid unnecessary biopsy than LRPpca or F/T ratio. RPpca could be valuable to decide whether to perform prostate biopsy when using various PSA kits.

摘要

背景

研究使用前列腺癌相对概率(RPpca)这一新概念是否能提高前列腺癌检测的敏感性和特异性。

方法

对217例总前列腺特异性抗原(PSA)水平为4 - 20 ng/mL的患者测量前列腺体积及游离PSA与总PSA(F/T)比值。根据前列腺癌阳性预测值与年龄、前列腺体积、总PSA或F/T比值之间的拟合曲线,确定每个预测前列腺癌的函数。计算每位患者由年龄、前列腺体积、总PSA和F/T比值的联合函数定义的RPpca。还使用逻辑回归分析(LRPpca)计算前列腺癌的概率。进行受试者操作特征分析以阐明传统参数和新参数的曲线下面积(AUC)、敏感性、特异性及临界值。最后,我们使用不同的PSA检测试剂盒(AxSYM)研究上述参数在另一患者组中的适用性。

结果

尽管在总PSA范围为4 - 20 ng/mL时RPpca的AUC最大,但RPpca与F/T比值或LRPpca之间未达到统计学显著性。F/T比值、LRPpca和RPpca的临界值分别确定为0.15、0.12和0.20。在AxSYM数据中使用这些临界值时,RPpca具有最高的敏感性(91%)和特异性(57%)。

结论

与LRPpca或F/T比值相比,RPpca可为避免不必要的活检提供更精确的信息。在使用各种PSA试剂盒时,RPpca对于决定是否进行前列腺活检可能具有重要价值。

相似文献

1
Determination of the relative probability for prostate cancer to avoid unnecessary biopsy.确定前列腺癌避免不必要活检的相对概率。
Int J Urol. 2005 Apr;12(4):346-52. doi: 10.1111/j.1442-2042.2005.01056.x.
2
Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.检测与α1-抗糜蛋白酶结合的前列腺特异性抗原,以避免血清前列腺特异性抗原水平在4 - 20 ng/mL的患者进行不必要的活检。
Int J Urol. 2005 Aug;12(8):721-7. doi: 10.1111/j.1442-2042.2005.01167.x.
3
Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.游离前列腺特异性抗原:其在多核心前列腺活检时代的应用价值。
Int J Urol. 2009 Jun;16(6):561-5. doi: 10.1111/j.1442-2042.2009.02304.x. Epub 2009 May 12.
4
Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.在总前列腺特异性抗原水平为2至4纳克/毫升范围内的游离前列腺特异性抗原百分比,与4至10纳克/毫升范围内相比,并不会显著增加检测临床显著性前列腺癌所需的活检次数。
J Urol. 2002 Aug;168(2):504-8.
5
[The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].[游离前列腺特异性抗原/总前列腺特异性抗原比值变异性在前列腺癌早期诊断中的发生率]
Prog Urol. 1997 Jun;7(3):455-63.
6
Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.用于预测血清PSA水平低于10 ng/mL的日本患者初次前列腺活检阳性概率的新列线图的开发。
Int J Urol. 2008 Jul;15(7):598-603. doi: 10.1111/j.1442-2042.2008.02058.x. Epub 2008 May 2.
7
Using multiple cutpoints for the free-to-total prostate specific antigen ratio improves the accuracy of prostate cancer detection.使用多个游离前列腺特异性抗原与总前列腺特异性抗原比值的切点可提高前列腺癌检测的准确性。
Prostate. 2002 Jul 1;52(2):150-8. doi: 10.1002/pros.10111.
8
[Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations].[联合使用前列腺特异性抗原密度和游离前列腺特异性抗原与总前列腺特异性抗原比值对前列腺特异性抗原升高患者进行癌症检测]
Hinyokika Kiyo. 2006 Feb;52(2):113-7.
9
Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).游离前列腺特异性抗原与总前列腺特异性抗原比值作为非器官局限性前列腺癌(pT3期)的预测指标
Scand J Urol Nephrol. 2003;37(6):466-70. doi: 10.1080/00365590310001746.
10
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.复合前列腺特异性抗原(PSA)可减少总PSA在2.6 - 4.0 ng/mL范围内不必要的前列腺活检。
BJU Int. 2004 Jul;94(1):47-50. doi: 10.1111/j.1464-410X.2004.04899.x.

引用本文的文献

1
Development of simultaneous detection of total prostate-specific antigen (tPSA) and free PSA with rapid bead-based immunoassay.基于快速胶乳增强免疫比浊法同时检测总前列腺特异性抗原(tPSA)和游离前列腺特异性抗原(fPSA)的方法学建立。
J Clin Lab Anal. 2011;25(1):37-42. doi: 10.1002/jcla.20427.
2
Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity.与前列腺特异性抗原(PSA)速度相比,人工神经网络(ANN)速度能更好地识别良性前列腺增生,但对前列腺癌的识别效果不佳。
BMC Urol. 2008 Sep 2;8:10. doi: 10.1186/1471-2490-8-10.
3
Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion.
游离前列腺特异性抗原(PSA)与总PSA的比值有助于提高日本人群中前列腺癌的检出率,该人群以2.1至10.0 ng/ml的PSA水平作为筛查标准。
Int J Clin Oncol. 2008 Jun;13(3):229-32. doi: 10.1007/s10147-007-0742-2. Epub 2008 Jun 14.